Quick Takeaways
- FMR LLC filed SCHEDULE 13G/A for CELLDEX THERAPEUTICS INC COMMON STOCK (CLDX).
- Disclosed ownership: 7.3%.
- Date of event: 31 Dec 2024.
FMR LLC - 31 Dec 2024 SCHEDULE 13G/A Report for CELLDEX THERAPEUTICS INC COMMON STOCK (CLDX)
- Filing Manager
- FMR LLC
- Reporting Manager
- FMR LLC
- Symbol
- CLDX
- Shares outstanding
- 66,543,397 shares
- Disclosed Ownership
- 4,857,668 shares
- Ownership
- 7.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Feb 2025, 09:28:12 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"FMR LLC disclosed 7.3% ownership in CELLDEX THERAPEUTICS INC COMMON STOCK (CLDX) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2025, 09:28.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FMR LLC | 7.3% | 4,857,668 | 4,855,957 | 0 | Stephanie J. Brown | Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* | |
| Abigail P. Johnson | 7.3% | 4,857,668 | 0 | 0 | Stephanie J. Brown | Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** |